<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">AJS</journal-id>
<journal-id journal-id-type="hwp">amjsports</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Sports Med</journal-id>
<journal-title>The American Journal of Sports Medicine</journal-title>
<issn pub-type="ppub">0363-5465</issn>
<issn pub-type="epub">1552-3365</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0363546513485917</article-id>
<article-id pub-id-type="publisher-id">10.1177_0363546513485917</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Analyzing Chondrocyte Viability: Letter to the Editor</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lawson</surname><given-names>Kevin A.</given-names></name>
<degrees>BA</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Teteak</surname><given-names>Colin J.</given-names></name>
<degrees>BA</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Liu</given-names></name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Gee</surname><given-names>Albert O.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Chansky</surname><given-names>Howard A.</given-names></name>
<degrees>MD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0363546513485917">Kevin A. Lawson (e-mail: <email>kevin.lawson@jefferson.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>5</issue>
<fpage>NP29</fpage>
<lpage>NP30</lpage>
<permissions>
<copyright-statement>© 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Orthopaedic Society for Sports Medicine</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p><bold>Dear Editor:</bold></p>
<p>In the November 2012 issue of the <italic>American Journal of Sports Medicine</italic>, Garrity et al<sup><xref ref-type="bibr" rid="bibr5-0363546513485917">5</xref></sup> published a controlled laboratory study (“Improved Osteochondral Allograft Preservation Using Serum-Free Media at Body Temperature”) that analyzed different medium and temperature effects on osteochondral graft composition and chondrocyte viability. From the results, the authors concluded that storage at 37°C, as opposed to the traditional and industry standard, 4°C, preserved osteochondral grafts better.</p>
<p>While we do not disagree with the findings reported, we would like to discuss the methods used to analyze chondrocyte viability. Traditionally, “fresh” osteochondral allografts were used within days of harvest, with good long-term clinical outcomes.<sup><xref ref-type="bibr" rid="bibr3-0363546513485917">3</xref></sup> As discussed by Garrity et al, increased screening secondary to concerns regarding disease transmission has prolonged the time period from tissue harvest to clinical use.<sup><xref ref-type="bibr" rid="bibr9-0363546513485917">9</xref></sup> This prolonged storage has led to decreased graft integrity and in vivo performance.<sup><xref ref-type="bibr" rid="bibr8-0363546513485917">8</xref></sup> In particular, after prolonged storage, chondrocyte viability decreases drastically.<sup><xref ref-type="bibr" rid="bibr1-0363546513485917">1</xref></sup> This leads to a diminished population of cells capable of maintaining articular cartilage integrity within the grafted tissue.<sup><xref ref-type="bibr" rid="bibr2-0363546513485917">2</xref></sup></p>
<p>Because of the increased chondrocyte death after prolonged storage, most literature studying the effects of storage conditions on graft integrity has analyzed chondrocyte viability. Several methods have been used for this analysis; however, the 2 most common reagents used are calcein-AM and ethidium homodimer (EtHd).<sup><xref ref-type="bibr" rid="bibr6-0363546513485917">6</xref></sup> In living cells, the hydrophobic calcein-AM crosses the cell membrane, where it is metabolized by intracellular esterases into a fluorescent molecule that cannot exit the cell. In contrast, EtHd is only able to enter cells with compromised cell membranes, where it intercalates with cellular DNA and gives off fluorescence. Therefore, calcein-AM should only fluoresce in viable cells with esterase activity and EtHd should only fluoresce in nonviable cells.</p>
<p>The combination of calcein-AM and EtHd is commercially sold as a staining kit, and its use has been validated by numerous studies in cell culture. However, recently the specificity of this staining system has been questioned when used with tissue sections and within 3-dimensional tissue scaffolds such as osteochondral grafts. In 2007, Lightfoot et al<sup><xref ref-type="bibr" rid="bibr7-0363546513485917">7</xref></sup> published a controlled laboratory study in the <italic>American Journal of Sports Medicine</italic> analyzing the validity of calcein-AM/EtHd staining for chondrocyte viability. In this study, the authors used chondrocyte yield as well as transmission electron microscopic (TEM) images as adjunct assessments of viability. When comparing stored osteochondral grafts to fresh osteochondral grafts, using calcein-AM/EtHd, the authors found that cell viability was similar between the two. However, when comparing chondrocyte yield they found that the stored grafts had a significant decrease in cell count compared with the fresh osteochondral grafts. Additionally, TEM showed an increased number of abnormal and nonviable cells (nuclear and cell membrane abnormalities) demonstrating signs of apoptosis. One explanation for this overestimation given by the authors was that when grafts are stored at 4°C, esterase activity is preserved and can metabolize calcein-AM within dead cells and give a false-positive signal.</p>
<p>A study from Gantenbein-Ritter et al<sup><xref ref-type="bibr" rid="bibr4-0363546513485917">4</xref></sup> in <italic>Tissue Engineering</italic> examined the accuracy of several cell viability techniques within a fibrin scaffold. Mixtures of differing concentrations of live and dead chondrocytes were seeded into the scaffold and then analyzed for cell viability. In this study, calcein-AM overestimated cell viability in each mixture. The authors hypothesized that inaccurate calculations used in the imaging caused by the scaffolding could be one possible cause for the results found. Similar imaging programs have been used in several studies using calcein-AM/EtHd to analyze cell viability in osteochondral grafts.</p>
<p>Finally, the calcein-AM/EtHd staining system has been shown to be widely inconsistent when comparing cell viabilities in similarly treated tissue across studies. For example, when investigators compared cell viability rates at 14 days of osteochondral grafts stored within lactated Ringer’s at 4°C, the studies from Teng et al<sup><xref ref-type="bibr" rid="bibr10-0363546513485917">10</xref></sup> and Ball et al<sup><xref ref-type="bibr" rid="bibr2-0363546513485917">2</xref></sup> had viability rates of 20.4% and 80.2%, respectively.</p>
<p>A viable cell population within articular grafts is thought to be responsible for long-term osteochondral graft success. Therefore, any attempt to optimize graft performance and clinical outcomes needs to focus on maintaining a healthy chondrocyte population. As we continue to study the optimal storage methods to preserve viable graft tissue, there is a need for a more specific, consistent, and accurate means of analyzing cell viability.</p>
<sig-block>
<sig>Kevin A. Lawson, BA<break/>
Colin J. Teteak, BA<break/>
Liu Yang, PhD<break/>
Albert O. Gee, MD<break/>
Howard A. Chansky, MD<break/>
<italic>Seattle, Washington</italic></sig>
</sig-block>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The authors declared that they have no conflicts of interest in the authorship and publication of this contribution.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0363546513485917">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Allen</surname><given-names>RT</given-names></name>
<name><surname>Robertson</surname><given-names>CM</given-names></name>
<name><surname>Pennock</surname><given-names>AT</given-names></name>
<etal/>
</person-group>. <article-title>Analysis of stored osteochondral allografts at the time of surgical implantation</article-title>. <source>Am J Sports Med</source>. <year>2005</year>;<volume>33</volume>:<fpage>1479</fpage>-<lpage>1484</lpage>.</citation>
</ref>
<ref id="bibr2-0363546513485917">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ball</surname><given-names>ST</given-names></name>
<name><surname>Amiel</surname><given-names>D</given-names></name>
<name><surname>Williams</surname><given-names>SK</given-names></name>
<etal/>
</person-group>. <article-title>The effects of storage on fresh human osteochondral allografts</article-title>. <source>Clin Orthop Relat Res</source>. <year>2004</year>;<volume>418</volume>:<fpage>246</fpage>-<lpage>252</lpage>.</citation>
</ref>
<ref id="bibr3-0363546513485917">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bugbee</surname><given-names>WD.</given-names></name>
</person-group> <article-title>Fresh osteochondral allografts</article-title>. <source>J Knee Surg</source>. <year>2002</year>;<volume>15</volume>(<issue>3</issue>):<fpage>191</fpage>-<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr4-0363546513485917">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gantenbein-Ritter</surname><given-names>B</given-names></name>
<name><surname>Potier</surname><given-names>E</given-names></name>
<name><surname>Zeiter</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Accuracy of three techniques to determine cell viability in 3D tissues or scaffolds</article-title>. <source>Tissue Eng Part C Methods</source>. <year>2008</year>;<volume>14</volume>:<fpage>353</fpage>-<lpage>358</lpage>.</citation>
</ref>
<ref id="bibr5-0363546513485917">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garrity</surname><given-names>JT</given-names></name>
<name><surname>Stoker</surname><given-names>AM</given-names></name>
<name><surname>Sims</surname><given-names>HJ</given-names></name>
<name><surname>Cook</surname><given-names>JL.</given-names></name>
</person-group> <article-title>Improved osteochondral allograft preservation using serum-free media at body temperature</article-title>. <source>Am J Sports Med</source>. <year>2012</year>;<volume>40</volume>(<issue>11</issue>):<fpage>2542</fpage>-<lpage>2548</lpage>.</citation>
</ref>
<ref id="bibr6-0363546513485917">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaplan</surname><given-names>LD.</given-names></name>
</person-group> <article-title>The analysis of articular cartilage after thermal exposure: “is red really dead?”</article-title> <source>Arthroscopy</source>. <year>2003</year>;<volume>19</volume>:<fpage>310</fpage>-<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr7-0363546513485917">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lightfoot</surname><given-names>A</given-names></name>
<name><surname>Martin</surname><given-names>J</given-names></name>
<name><surname>Amendola</surname><given-names>A.</given-names></name>
</person-group> <article-title>Fluorescent viability stains overestimate chondrocyte viability in osteoarticular allografts</article-title>. <source>Am J Sports Med</source>. <year>2007</year>;<volume>35</volume>:<fpage>1817</fpage>-<lpage>1823</lpage>.</citation>
</ref>
<ref id="bibr8-0363546513485917">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Malinin</surname><given-names>T</given-names></name>
<name><surname>Temple</surname><given-names>HT</given-names></name>
<name><surname>Buck</surname><given-names>BE.</given-names></name>
</person-group> <article-title>Transplantation of osteochondral allografts after cold storage</article-title>. <source>J Bone Joint Surg Am</source>. <year>2006</year>;<volume>88</volume>:<fpage>762</fpage>-<lpage>770</lpage>.</citation>
</ref>
<ref id="bibr9-0363546513485917">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pallante</surname><given-names>AL</given-names></name>
<name><surname>Bae</surname><given-names>WC</given-names></name>
<name><surname>Chen</surname><given-names>AC</given-names></name>
<etal/>
</person-group>. <article-title>Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts</article-title>. <source>Am J Sports Med</source>. <year>2009</year>;<volume>37</volume>(<supplement>suppl 1</supplement>):<fpage>24S</fpage>-<lpage>32S</lpage>.</citation>
</ref>
<ref id="bibr10-0363546513485917">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teng</surname><given-names>MS</given-names></name>
<name><surname>Yuen</surname><given-names>AS</given-names></name>
<name><surname>Kim</surname><given-names>HT.</given-names></name>
</person-group> <article-title>Enhancing osteochondral allograft viability: effects of storage media composition</article-title>. <source>Clin Orthop Relat Res</source>. <year>2008</year>;<volume>466</volume>(<issue>8</issue>):<fpage>1804</fpage>-<lpage>1809</lpage>.</citation>
</ref>
</ref-list>
</back>
<sub-article article-type="letter" id="sub1-0363546513485917">
<front-stub>
<title-group>
<article-title>Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Garrity</surname><given-names>Joseph T.</given-names></name>
<degrees>MS</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Stoker</surname><given-names>Aaron M.</given-names></name>
<degrees>MS, PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Cook</surname><given-names>James L.</given-names></name>
<degrees>DVM, PhD</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp2-0363546513485917">Joseph T. Garrity (e-mail: <email>jtgdk7@mail.missouri.edu</email>).</corresp>
</author-notes>
</front-stub>
<body>
<p><bold>Authors’ Response:</bold></p>
<p>Thank you for your interest in our work and your thoughtful discussion regarding cell viability.<sup><xref ref-type="bibr" rid="bibr11-0363546513485917">1</xref></sup> We agree that chondrocyte viability at the time of implantation is a critical factor for clinical success of osteochondral allografts, and, as such, accurate assessment of viability is vital as an outcome measure in this area of research. We appreciate your input and recommendations regarding the techniques used and most certainly will take your recommendations into consideration for our future work. Thank you for agreeing with the results of the study and their potential clinical importance. We recognize the inconsistencies seen in cell viability by storing at 4°C; however, our results after 28 days of storage at 37°C were very similar to those seen by Pallante et al.<sup><xref ref-type="bibr" rid="bibr12-0363546513485917">2</xref></sup> Also, because we used multiple outcome measures and applied them consistently across groups, we feel that the comparisons made between preservation techniques were fair and valid and allow for the conclusions with respect to clinical application discussed in the article. In addition, our ongoing in vivo work has provided further evidence for the importance of assessing chondrocyte viability at the time of implantation (manuscripts in review) in that grafts with high chondrocyte viability (assessed by calcein-AM/EtHd and a novel metabolic assay) were associated with superior functional outcomes (using multiple clinical relevant outcome measures) in a canine model.</p>
<p>Thank you again for your attention to our work and your important input regarding further work in this exciting area.</p>
<sig-block>
<sig>Joseph T. Garrity, MS<break/>
Aaron M. Stoker, MS, PhD<break/>
James L. Cook, DVM, PhD<break/>
<italic>Columbia, Missouri</italic></sig>
</sig-block>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>One or more of the authors has declared the following potential conflict of interest or source of funding: The original study was funded by the Comparative Orthopaedic Laboratory at the University of Missouri. Drs Cook and Stoker have US patents pending on the preservation system used in the study.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr11-0363546513485917">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garrity</surname><given-names>JT</given-names></name>
<name><surname>Stoker</surname><given-names>AM</given-names></name>
<name><surname>Sims</surname><given-names>HJ</given-names></name>
<name><surname>Cook</surname><given-names>JL.</given-names></name>
</person-group> <article-title>Improved osteochondral allograft preservation using serum-free media at body temperature</article-title>. <source>Am J Sports Med</source>. <year>2012</year>;<volume>40</volume>(<issue>11</issue>):<fpage>2542</fpage>-<lpage>2548</lpage>.</citation>
</ref>
<ref id="bibr12-0363546513485917">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pallante</surname><given-names>AL</given-names></name>
<name><surname>Bae</surname><given-names>WC</given-names></name>
<name><surname>Chen</surname><given-names>AC</given-names></name>
<etal/>
</person-group>. <article-title>Chondrocyte viability is higher after prolonged storage at 37 degrees C than at 4 degrees C for osteochondral grafts</article-title>. <source>Am J Sports Med</source>. <year>2009</year>;<volume>37</volume>(<supplement>suppl 1</supplement>):<fpage>24S</fpage>-<lpage>32S</lpage>.</citation>
</ref>
</ref-list>
</back>
</sub-article>
</article>